BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 26290123)

  • 1. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
    Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
    Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contraception-related venous thromboembolism in a pediatric institution.
    Pillai P; Bonny AE; O'Brien SH
    J Pediatr Adolesc Gynecol; 2013 Jun; 26(3):186-8. PubMed ID: 23566795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
    Plu-Bureau G; Horellou MH; Gompel A; Conard J
    Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
    van Vlijmen EF; Wiewel-Verschueren S; Monster TB; Meijer K
    J Thromb Haemost; 2016 Jul; 14(7):1393-403. PubMed ID: 27121914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J; Assmann A; Möhner S; Minh TD
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
    Mills A; Wilkinson C; Fotherby K
    Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in young female while on oral contraceptives: high frequency of inherited thrombophilia and analysis of thrombotic events in 400 czech women.
    Dulícek P; Malý J; Pecka M; Beránek M; Cermáková E; Malý R
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):567-73. PubMed ID: 19117968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined hormonal contraception and the risk of venous thromboembolism: a guideline.
    ;
    Fertil Steril; 2017 Jan; 107(1):43-51. PubMed ID: 27793376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic risks of oral contraceptives.
    Rott H
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N; Smith KP
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception.
    Cosmi B; Legnani C; Bernardi F; Coccheri S; Palareti G
    Arch Intern Med; 2003 May; 163(9):1105-9. PubMed ID: 12742811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraception in women with mild thrombophilia: what have we learned recently?
    Blanco-Molina Á
    Thromb Res; 2012 Oct; 130 Suppl 1():S16-8. PubMed ID: 23026651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined hormonal contraception and venous thromboembolism.
    Martínez F; Avecilla A
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
    Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
    Hugon-Rodin J; Horellou MH; Conard J; Gompel A; Plu-Bureau G
    Thromb Haemost; 2018 May; 118(5):922-928. PubMed ID: 29614525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal contraception in thrombophilic adolescents: risk of thrombosis and recommendations.
    Rott H
    Hamostaseologie; 2012; 32(1):15-21. PubMed ID: 22009044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism in women: a specific reproductive health risk.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2013; 19(5):471-82. PubMed ID: 23825156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanese women.
    Sugiura K; Kobayashi T; Ojima T
    Thromb Res; 2016 Jan; 137():11-16. PubMed ID: 26672897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of a male or female thrombotic family history on contraceptive counseling: a cohort study.
    van Vlijmen EF; Veeger NJ; Middeldorp S; Hamulyák K; Prins MH; Kluin-Nelemans HC; Meijer K
    J Thromb Haemost; 2016 Sep; 14(9):1741-8. PubMed ID: 27327043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study.
    Sundquist K; Sundquist J; Svensson PJ; Zöller B; Memon AA
    J Thromb Haemost; 2015 Dec; 13(12):2180-6. PubMed ID: 26407905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.